Clinical Internship with the Pediatric Clinic's Clinical Research at the Patient Care Center of the University of North Texas Health Science Center/Texas College of Osteopathic Medicine: Literature Review of Meningococcal Meningitis
Date
Authors
ORCID
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Epidemic meningococcal meningitis and meningococcemia disease is caused by the bacterial pathogen Neisseria meningitidis. Once infected with meningococci, onset of the disease is rapid with a high rate or morbidity and mortality. Without medical intervention the mortality rate is over 50%. Medical treatment is over 50%. Medical treatment of an outbreak of the disease with antibiotics can reduce the death rate to 10-15%. However, 10-20% of survivors will suffer from neurological damage that may include loss of hearing, paralysis or mental retardation. Recent concerns have been noted regarding the emergence of Neisseria meningitidis strains resistant to antibiotics. Vaccines have been developed in an effort to reduce epidemic outbreaks of meningococcal meningitis and meningococcemia. The first generation polysaccharide vaccines have shown to be safe and possess some degree of effectiveness but have shortcomings of limited length of immune protection and evidence of hyporesponsiveness to subsequent vaccinations. The second generation conjugated polysaccharide vaccines have been able to overcome these problems and show great promise in reducing the sale of epidemic meningococcal outbreaks with implementation of effective mass vaccination campaigns. In addition, reducing the number of infections will limit the exposure of Neisseria meningitidis to antibiotics and, in theory, slow the development of resistance to antibiotics.
Description
Keywords
Clinical Epidemiology
Health Services Research
Life Sciences
Medicine and Health Sciences
Nervous System Diseases
Neuroscience and Neurobiology
Other Pharmacy and Pharmaceutical Sciences
Other Public Health
Pharmacy and Pharmaceutical Sciences
Public Health
Epidemic
meningococcal meningitis
meningococcemia disease
bacterial pathogen
Neisseria meningitidis
meningococci
mortality
medical treatment
neurological damage
vaccines
antibiotics
clinical internship